INHIBITION OF THE ANGIOTENSIN II TYPE 2 RECEPTOR AT2R IS A NOVEL THERAPEUTIC STRATEGY FOR GLIOBLASTOMA

Perryman, R; Renziehausen, A; Shaye, H; Kostagianni, A; Tsiailanis, A; Thorne, T; Chatziathanasiadou, M; Sivolapenko, G; El Mubarak, MA; Han, GW; Zarzycka, B; Katritch, V; Lebon, G; Lo Nigro, C; Lattanzio, L; Morse, S; Choi, J; O'Neill, K; Kanaki, Z; Klinakis, A; Crook, T; Cherezov, V; Tzakos, A; Syed, N

NEURO-ONCOLOGY, 2022; 24 (): 212